Transcriptomics

Dataset Information

0

BCLXL PROTAC degrader DT2216 targets secondary plasma cell leukemia addicted to BCLXL for survival

ABSTRACT: We demonstrated that secondary Plasma Cell Leukemia, addicted to BCLXL, a small but a very challenging group of patients, could benefit from DT2216, underpinning its clinical evaluation.

ORGANISM(S): Homo sapiens

PROVIDER: GSE222016 | GEO | 2024/01/30

REPOSITORIES: GEO

Json Xml

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

Genomics BCLXL PROTAC degrader DT2216 targets secondary plasma cell leukemia addicted to BCLXL for survival
| PRJNA917319 | ENA
Unknown BCLXL PROTAC degrader DT2216 targets secondary plasma cell leukemia addicted to BCLXL for survival.
| S-EPMC10393035 | biostudies-literature
Unknown Discovery of an LSD1 PROTAC degrader.
| S-EPMC12107161 | biostudies-literature
Unknown Discovery of the First-in-class G9a/GLP PROTAC Degrader.
| S-EPMC10925177 | biostudies-literature
Unknown Discovery of a potent and selective PROTAC degrader for STAT3.
| S-EPMC12311991 | biostudies-literature
Unknown Discovery of the First-in-Class G9a/GLP PROTAC Degrader.
| S-EPMC11069390 | biostudies-literature
Genomics Next-generation sequencing of cholinergic interneurons in the nucleus accumbens of cocaine-addicted and non-addicted mice
| PRJNA539941 | ENA
Unknown BRD3 PROTAC degrader targets H3K18ac to alleviate retinal microglia-driven uveitis.
| S-EPMC12828559 | biostudies-literature
Unknown A BPTF-specific PROTAC degrader enhances NK cell-based cancer immunotherapy.
| S-EPMC11997503 | biostudies-literature
Unknown Lethal activity of BRD4 PROTAC degrader QCA570 against bladder cancer cells.
| S-EPMC9887192 | biostudies-literature